Literature DB >> 30483740

Characterization of circRNA‑associated ceRNA networks in patients with nonvalvular persistent atrial fibrillation.

Yangyang Zhang1, Xianting Ke1, Jingjing Liu1, Xiue Ma1, Yi Liu1, Dandan Liang1, Luxin Wang1, Changfa Guo2, Yiwei Luo1.   

Abstract

Circular RNAs (circRNAs) are non-coding RNAs forming closed-loop structures, and their aberrant expression may lead to disease. However, the potential network of circRNA‑associated competing endogenous RNA (ceRNA) involved in nonvalvular persistent atrial fibrillation (NPAF) has not been previously reported. In the present study, four left atrial appendages (LAA) of patients with NPAF and four normal LAAs were examined via RNA sequencing, and their potential functions were investigated via bioinformatics analysis. The circRNA‑enriched genes were analyzed using Gene Ontology (GO) categories, while the enrichment of circRNAs was detected via the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. A total of 296 significantly dysregulated circRNA transcripts were obtained, with 238 upregulated and 58 downregulated. A number of circRNAs were further confirmed using reverse transcription‑quantitative polymerase chain reaction analysis. Furthermore, the more comprehensive circRNA‑associated ceRNA networks were examined in patients with NPAF. GO categories and KEGG annotation analysis of circRNAs revealed that the circRNA‑associated ceRNA networks were likely to influence AF though alterations in calcium and cardiac muscle contraction. The circRNA‑associated ceRNA networks revealed that dysregulated circRNAs in NPAF may be involved in regulating hsa‑microRNA (miR)‑208b and hsa‑miR‑21. To the best of our knowledge, this study presents the circRNA‑associated ceRNA networks in NPAF for the first time, which may have potential implications for the pathogenesis of AF. This study reveals a potential perspective from which to investigate circRNAs in circRNA‑associated ceRNA networks (hsa_circRNA002085, hsa_circRNA001321) in NPAF, and provides a potential biomarker for AF.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30483740     DOI: 10.3892/mmr.2018.9695

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

1.  Circ-0001313/miRNA-510-5p/AKT2 axis promotes the development and progression of colon cancer.

Authors:  Fang-Ling Tu; Xi-Qing Guo; Hai-Xia Wu; Zhi-Yun He; Fang Wang; Ai-Jun Sun; Xu-Dong Dai
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

2.  Hsa_circ_0000285 functions as a competitive endogenous RNA to promote osteosarcoma progression by sponging hsa-miRNA-599.

Authors:  Zhicai Zhang; Feifei Pu; Baichuan Wang; Qiang Wu; Jianxiang Liu; Zengwu Shao
Journal:  Gene Ther       Date:  2019-11-29       Impact factor: 5.250

3.  A Novel Circular RNA, circ_0005394, Predicts Unfavorable Prognosis and Contributes to Hepatocellular Carcinoma Progression by Regulating miR-507/E2F3 and miR-515-5p/CXCL6 Signaling Pathways.

Authors:  Chengming Sun; Guodong Li; Ming Liu
Journal:  Onco Targets Ther       Date:  2020-06-29       Impact factor: 4.147

Review 4.  Circular RNA in Diseased Heart.

Authors:  Ying Wang; Bin Liu
Journal:  Cells       Date:  2020-05-17       Impact factor: 6.600

Review 5.  Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story.

Authors:  Ugo Ala
Journal:  Cells       Date:  2020-06-28       Impact factor: 6.600

6.  Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases.

Authors:  Xiyu Zhu; Xinlong Tang; Hoshun Chong; Hailong Cao; Fudong Fan; Jun Pan; Dongjin Wang; Qing Zhou
Journal:  Front Cardiovasc Med       Date:  2020-11-20

Review 7.  Circular RNAs in Sudden Cardiac Death Related Diseases: Novel Biomarker for Clinical and Forensic Diagnosis.

Authors:  Meihui Tian; Zhipeng Cao; Hao Pang
Journal:  Molecules       Date:  2021-02-21       Impact factor: 4.411

Review 8.  Exosomes and Exosomal Non-coding RNAs Are Novel Promises for the Mechanism-Based Diagnosis and Treatments of Atrial Fibrillation.

Authors:  Chaofeng Chen; Qingxing Chen; Kuan Cheng; Tian Zou; Yang Pang; Yunlong Ling; Ye Xu; Wenqing Zhu
Journal:  Front Cardiovasc Med       Date:  2021-12-01

Review 9.  A narrative review of non-coding RNAs in atrial fibrillation: potential therapeutic targets and molecular mechanisms.

Authors:  Lan Zhang; Xi Wang; Congxin Huang
Journal:  Ann Transl Med       Date:  2021-09

10.  Integrative Analysis Reveals Key Circular RNA in Atrial Fibrillation.

Authors:  Xiaofeng Hu; Linhui Chen; Shaohui Wu; Kai Xu; Weifeng Jiang; Mu Qin; Yu Zhang; Xu Liu
Journal:  Front Genet       Date:  2019-02-19       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.